Programmable CSF Shunt Valve: In Vitro Assessment of MR Imaging Safety at 3T

References

1. ↵
   Czosnyka Z, Czosnyka M, Richards H, et al. Hydrodynamic properties of hydrocephalus shunts. Acta Neurochir Suppl 1998;71:334–39

   PubMed
2. ↵
   Ludemann W, Rosahl SK, Kaminsky J, et al. Reliability of a new adjustable shunt device without the need for readjustment following 3-Tesla MRI. Childs Nerv Syst 2005;21:227–29

   CrossRefPubMed
3. ↵
   Miwa K, Kondo H, Sakai N. Pressure changes observed in Codman-Medos programmable valves following magnetic exposure and flipping. Childs Nerv Syst 2001;17:150–53

   CrossRefPubMed
4. Ortler M, Kostron H, Felber S. Transcutaneous pressure-adjustable valves and magnetic resonance imaging: an ex vivo examination of the Codman-Medos programmable valve and the Sophy adjustable pressure valve. Neurosurgery 1997;40:1050–57

   CrossRefPubMed
5. Fransen P, Dooms G, Thauvoy C. Safety of the adjustable pressure ventricular valve in magnetic resonance imaging: problems and solutions. Neuroradiology 1992;34:508–09

   CrossRefPubMed
6. ↵
   Fransen P. Transcutaneous pressure-adjustable valves and magnetic resonance imaging: an ex vivo examination of the Codman-Medos programmable valve and the Sophy adjustable pressure valve. Neurosurgery 1998;42:430

   PubMed
7. ↵
   Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004;232:635–52

   CrossRefPubMedWeb of Science
8. ↵
   Shellock FG. Reference Manual For Magnetic Resonance Safety, Implants, and Devices: 2006 Edition. Los Angeles, Calif; Biomedical Research Publishing Group;2006
9. ↵
   Anderson RC, Walker ML, Viner JM, et al. Adjustment and malfunction of a programmable valve after exposure to toy magnets. J Neurosurg 2004;101:222–25

   PubMed
10. ↵
    Schneider T, Knauff U, Nitsch J, et al. Electromagnetic field hazards involving adjustable shunt valves in hydrocephalus. J Neurosurg 2002;96:331–34

    CrossRefPubMed
11. ↵
    Shellock FG, Cosendai G, Park SM, et al. Implantable microstimulator: magnetic resonance safety at 1.5-Tesla. Invest Radiol 2004;39:591–99

    CrossRefPubMed
12. ↵
    Shellock FG, Gounis M, Wakhloo A. Detachable Coil for cerebral aneurysms: in vitro evaluation of magnet field interactions, heating, and artifacts at 3-Tesla. AJNR Am J Neuroradiol 2005;26:363–66

    Abstract/FREE Full Text
13. ↵
    Shellock FG, Forder J. Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3-Tesla. J Cardiovasc Magn Reson 2005;7:415–19

    CrossRefPubMedWeb of Science
14. ↵
    Shellock FG. Biomedical implants and devices: assessment of magnetic field interactions with a 3.0-Tesla MR system. J Magn Reson Imaging 2002;16:721–32

    CrossRefPubMedWeb of Science
15. ↵
    American Society for Testing and Materials (ASTM) International: F2052. Standard test method for measurement of magnetically induced displacement force on passive implants in the magnetic resonance environment. In: Annual Book of ASTM Standards: Medical Devices and Services. Vol.13.01 . West Conshohocken, Pa: American Society for Testing and Materials;2001 :1576–80
16. ↵
    American Society for Testing and Materials (ASTM) International: F2182–02 Test method for measurement of radio-frequency induced heating near passive implants during magnetic resonance imaging. Annual Book of ASTM Standards: Medical Devices and Services. Vol.13.01 . West Conshohocken, Pa: American Society for Testing and Materials;2003